| Literature DB >> 36185882 |
Zigale Hibstu1, Andargachew Mullu2, Adane Mihret3, Hylemariam Mihiretie Mengist4.
Abstract
OBJECTIVE: Bacterial meningitis (BM) is a public health threat with considerable mortality and morbidity worldwide; particularly in the meningitis belt of Africa where Ethiopia is located. The study aims to assess the prevalence, antibiogram, and associated factors of bacteria isolated from presumptive meningitis patients at Debre Markos Comprehensive Specialized Hospital (DMCSH), Northwest Ethiopia.Entities:
Keywords: antimicrobial susceptibility; associated factors; bacterial meningitis; ethiopia; patients
Year: 2022 PMID: 36185882 PMCID: PMC9514544 DOI: 10.7759/cureus.28500
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Sociodemographic characteristics of presumptive meningitis patients at DMCSH, Northwest Ethiopia, 2021
*Indicates education starting from kindergarten (zero class), $Indicates unemployed, self-employed, daily laborer, etc.
DMCSH - Debre Markos Comprehensive Specialized Hospital
| Characteristics | Frequency N (%) | Culture positive N (%) | |
| Sex | Male | 76 (50) | 10 (13.2) |
| Female | 76 (50) | 7 (9.2) | |
| Age in years | ≤5 | 68 (44.7) | 6 (8.8) |
| 6-18 | 30 (19.7)) | 3 (10) | |
| ≥18 | 54 (35.6) | 8(14.8) | |
| Education | Not at all | 47(30.9) | 8 (17) |
| 0-8* | 61 (40.1) | 5 (8.2) | |
| 9-12 | 26 (17.1) | 2 (7.7) | |
| College and above | 18 (11.8) | 2 (1.1) | |
| Occupation | Farmer | 53(34.9) | 6 (11.3) |
| Merchant | 25(16.4) | 1 (4) | |
| Government employee | 14(9.2) | 1 (7.1) | |
| Housewife | 10(6.6) | 0 (0) | |
| Student | 43(28.3) | 6 (14) | |
| Others$ | 7(4.6) | 3 (42.9) | |
| Residence | Rural | 78 (51.3) | 11 (14.1) |
| Urban | 74 (48.7) | 6 (8.1) | |
Antimicrobial susceptibility pattern of Gram-positive bacterial pathogens among presumptive meningitis patients at DMCSH, Northwest Ethiopia, 2021
AMO=Amoxacillin; AMP=Ampicillin; P=PenicillinG; SXT=Trimethoprim-sulphamethoxazole; CXM=Cefotaxime; CXT=Cefotaxin; FOX= cefoxitin; CEF= Ceftriaxone, C= Chloroamphenicol, IMP=Imipenem, VAN= Vancomtcin, COTRI= CO-trimoxazole, AZI= Azithromycin, OXA= OxacillinS=Susceptible; R= Resistant; NT = Not tested
| Bacteria isolated | Antibacterial susceptibility pattern | |||||||||||
| Amp | P | FOX | C | SXT | CXM | IMP | VAN | COTRI | AZITH | OXA | ||
|
| S (%) | NT | NT | 0 | 100 | NT | NT | NT | NT | NT | NT | NT |
| R (%) | NT | NT | 100 | 0 | NT | NT | NT | NT | NT | NT | NT | |
|
| S (%) | NT | 100 | 100 | 100 | NT | NT | 100 | 100 | 100 | 100 | NT |
| R (%) | NT | 0 | 0 | 0 | NT | NT | 0 | 0 | 0 | NT | NT | |
| CoNS (n= 1) | S (%) | NT | NT | NT | 0 | NT | NT | NT | NT | NT | NT | 100 |
| R (%) | NT | NT | NT | 100 | NT | NT | NT | NT | NT | NT | 0 | |
|
| S (%) | 0 | NT | 0 | 0 | 0 | 0 | NT | NT | NT | NT | NT |
| R (%) | 100 | 100 | 100 | 100 | 100 | 100 | NT | NT | NT | NT | NT | |
Antimicrobial susceptibility pattern of Gram-negative bacterial pathogens among presumptive meningitis patients at DMCSH, Northwest Ethiopia, 2021
Gen=gentamycin, Fox= cefoxitin, CXM= cefotaxime, Imp= imipenem, Amp= ampicillin, Cxt= cefotaxin, C=chloroamphinecol, Mer=meropenem, P=pencillin, SXT=Trimethoprim-sulphamethoxazole, Cef= Ceftriaxzone; NT = Not tested; S=sensitive; R= resistance
| Bacteria isolate | Antibacterial susceptibility test | ||||||||||||
| Gen | Fox | Cxm | Imp | Cef | Amp | Amk | SXT | C | Mero | P | Cxt | ||
|
| S (%) | 0 | 0 | 0 | 100 | 0 | 0 | 100 | 20 | 0 | 100 | NT | 0 |
| R (%) | 100 | 100 | 100 | 0 | 100 | 100 | 0 | 80 | 100 | 0 | NT | 100 | |
|
| S (%) | NT | 0 | 0 | NT | 100 | 0 | NT | NT | 0 | NT | 0 | 0 |
| R (%) | NT | 100 | 100 | NT | 100 | 100 | NT | NT | 100 | NT | 100 | 100 | |
|
| S (%) | NT | NT | 100 | NT | 100 | NT | NT | NT | NT | NT | 0 | NT |
| R (%) | NT | NT | 0 | NT | 0 | NT | NT | NT | NT | NT | 100 | NT | |
Multidrug resistance patterns bacteria isolated from presumptive meningitis patients at DMCSH, Northwest Ethiopia, 2021
| Group | Bacteria | Drugs | Drug class | Level of resistance |
| Gram-positive | | Ampicillin, | Pencillins | 100% |
| Cefoxitin, cefotaxime, cefotaxin | Third generation cephalosporins | |||
| Chloramphenicol | Chloramphenicol | |||
| Co-trimoxazole | Salphonomides | |||
| Gram-negative | | Ampicillin, Pencillin G | Pencillins | 100% |
| Cefoxitin, Cefotaxime, Cefotaxin, Ceftriaxone | Third generation cephalosporins | |||
| | Imipenem, Meropenem | Carabapenem | 100% | |
| Gentamycin, Amikacin | Aminoglycosides | |||
| Trimethoprim sulphamethoxazole | Sulphonamides | |||
| Cefoxitin, Cefotaxime, Cefotaxin, Ceftriaxone | Third generation cephalosporins |
Association of sociodemographic and clinical factors with bacterial isolates among presumptive meningitis patients at DMCSH, Northwest Ethiopia, 2021
*P-value <0.05, OR= Odds ratio; 95% CI=95% confidence interval. NA= Not applicable
| Characteristics | Culture positive N (%) | OR (95% CI) | P-value | |
| Sex | Male | 10(58.8) | 1 1.49(0.54-4.156 | 0.442 |
| Female | 7(41.2) | |||
| Residence | Rural | 11(1 4.1) | 1 1.86(0.19-4.54) | 0.25 |
| Urban | 6(8.1 | |||
| No | 8(9.8) | |||
| Duration of illness | ≤a week | 14 (15.2) | 3.41(0.29-9.74) | 0.999 |
| >a week | 57(95) | |||
| Tonsillectomy | Yes | 9(17) | 13.5.07(1.3-111.5) 1 | 0.03* |
| No | 8(8.1) | |||
| Vaccination | Yes | 6(37.5) | 1 6.81(1.3-94.567) | 0.02* |
| No | 11(8.1) | |||
| Previous drug use | Yes | 6(8.6) | 1 0.60(0.578-4.725) | 0.349 |
| No | 11(13.4) | |||
| Admission history | Yes | 3(15.8) | 1 1.59(0.162-2.425) | 0.499 |
| No | 14(10.5) | |||
| Comorbidity | Yes | 3(15.8) | 1.59(0.162-2.425) 1 | 0.499 |
| No | 14(10.5) | |||